Studies on the metabolism and effect on the CYP450 of CH330331 in rat liver microsomes
Sun Hai-yan, Fan He, Huichang Bi, Huang Wen-lin, Min Huang
Abstract
Sun Hai-yan, Fan He, Huichang Bi, Huang Wen-lin, Min Huang
Abstract
AIM:To study the metabolic kinetics of CH330331 in rat liver microsome,and its inhibition on CYP450 subtypes in the cocktail models.METHODS:The incubation parameters in rat liver microsome were optimized and were the Michaelis-Menten parameters Km and Vmax estimated the component of probe inhibitors in cocktail models were also confirmed and the effect of CH330331 on main subtypes of cytochrome P450 studied.RESULTS:The Km and Vmax of CH330331 were 18.96 μmol/L and 2.08 μmol/(min·mg protein),respectively.CH330331 had a weakly inhibition to the activity of CYP1A2,CYP2D6 and CYP2C9 but had no effect on CYP2C19,CYP2E1,and CYP3A4.CONCLUSION:CH330331 can increase the blood concentration of those drugs that are metabolized mainly by CYP1A2,CYP2D6 and CYP2C9.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the metabolic kinetics of CH330331 in rat liver microsome,and its inhibition on CYP450 subtypes in the cocktail models.METHODS:The incubation parameters in rat liver microsome were optimized and were the Michaelis-Menten parameters Km and Vmax estimated the component of probe inhibitors in cocktail models were also confirmed and the effect of CH330331 on main subtypes of cytochrome P450 studied.RESULTS:The Km and Vmax of CH330331 were 18.96 μmol/L and 2.08 μmol/(min·mg protein),respectively.CH330331 had a weakly inhibition to the activity of CYP1A2,CYP2D6 and CYP2C9 but had no effect on CYP2C19,CYP2E1,and CYP3A4.CONCLUSION:CH330331 can increase the blood concentration of those drugs that are metabolized mainly by CYP1A2,CYP2D6 and CYP2C9.
Key concepts: CYP1A2, Microsome, CYP2C9, CYP3A4, CYP2E1, Cytochrome P450, CYP2C19, CYP2D6